SAWGRASS PHARMA
Live / Allowed — Published for opposition (as of 24 Feb 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 08 Sept 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99380326
- Mark type
- Stylized text
- Filed
- 08 Sept 2025
- Published for opposition
- 24 Feb 2026
- Attorney of record
- Luna M. Samman
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in gastrointestinal, cardiovascular, psychiatry and neurology; pharmaceutical preparations for medical purposes, namely, antibiotics, anti-infectives, anti-diabetic, anti-allergic, antihypertensives, antidiarrheals, nonsteroidal anti-inflammatory drugs (NSAIDs), antiarrhythmics, skeletal muscle relaxants, anticholinergics, antimalarials, analgesics, vaccines and hormones, and pharmaceuticals addressing the needs of specific medical and therapeutic areas in the gastrointestinal, cardiovascular, psychiatry and neurology fields
Owner
- Unichem Pharmaceuticals (USA), Inc., East Brunswick, NJ, US
- Unichem Pharmaceuticals (USA), Inc., East Brunswick, NJ, US
Prosecution history
- 24 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Feb 2026 — PUBLISHED FOR OPPOSITION
- 18 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 30 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 Jan 2026 — EXAMINER'S AMENDMENT ENTERED
- 30 Jan 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 30 Jan 2026 — EXAMINERS AMENDMENT E-MAILED
- 30 Jan 2026 — EXAMINERS AMENDMENT -WRITTEN
- 22 Jan 2026 — ASSIGNED TO EXAMINER
- 08 Sept 2025 — APPLICATION FILING RECEIPT MAILED
- 08 Sept 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 08 Sept 2025 — NEW APPLICATION ENTERED